Literature DB >> 10819474

Significant changes in the serum levels of IL-6, h-HGF, and type IV collagen 7S during the perioperative period of a hepatectomy: relevance to SIRS.

K Namekata1, S Takamori, K Kojima, T Beppu, S Futagawa.   

Abstract

We analyzed the changes in the serum levels of both interleukin-6 (IL-6), human hepatocyte growth factor (h-HGF), and type IV collagen 7S (7S) during the perioperative period of a hepatectomy and evaluated their relationship with systemic inflammatory response syndrome (SIRS). The study subjects consisted of 40 patients who underwent a hepatectomy. In 14 out of 40 patients, postoperative SIRS(+) was observed. Between the SIRS(+) and SIRS(-) cases, there were significant differences in the preoperative values of prothrombin time, hepaplastin test, cholinesterase, and indocyanine green retention at 15 min (P < 0.01). Compared with the SIRS(-) cases, the IL-6, h-HGF, and 7S of the SIRS(+) cases fluctuated in a higher range and remained significantly higher after postoperative day 1 (P < 0.05). Eight out of 14 SIRS(+) patients had postoperative complications. In the 8 SIRS(+) patients with postoperative complications and in the 4 patients in which the SIRS(+) state lasted 3 days or longer, the 7S levels were significantly higher during the perioperative period (P < 0.05). In the SIRS(+) cases, the postoperative levels of IL-6 and h-HGF, as well as pre- and postoperative levels of 7S, were elevated. We therefore consider these levels to be risk factors for complications during the perioperative period of a hepatectomy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10819474     DOI: 10.1007/s005950050612

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  18 in total

1.  Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients.

Authors:  T Tomiya; M Tani; S Yamada; S Hayashi; N Umeda; K Fujiwara
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

2.  Hepatocyte growth factor.

Authors:  G K Michalopoulos; R Zarnegav
Journal:  Hepatology       Date:  1992-01       Impact factor: 17.425

Review 3.  Systemic inflammatory response syndrome.

Authors:  M G Davies; P O Hagen
Journal:  Br J Surg       Date:  1997-07       Impact factor: 6.939

Review 4.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

5.  The role of interleukin-6, interleukin-16, tumor necrosis factor-alpha and endotoxin in hepatic resection.

Authors:  M Shimada; T Matsumata; A Taketomi; K Shirabe; K Yamamoto; K Takenaka; K Sugimachi
Journal:  Hepatogastroenterology       Date:  1995 Sep-Oct

Review 6.  Changes of the extracellular matrix and cells producing it in acute liver injury.

Authors:  T Ueno; S Inuzuka; K Tanikawa
Journal:  Gastroenterol Jpn       Date:  1993-03

7.  Hepatic fibrosis in rats produced by carbon tetrachloride and dimethylnitrosamine: observations suggesting immunoassays of serum for the 7S fragment of type IV collagen are a more sensitive index of liver damage than immunoassays for the NH2-terminal propeptide of type III procollagen.

Authors:  L Ala-Kokko; V Günzler; J B Hoek; E Rubin; D J Prockop
Journal:  Hepatology       Date:  1992-07       Impact factor: 17.425

Review 8.  Bacterial translocation in multiple organ failure: cause or epiphenomenon still unproven.

Authors:  L C Lemaire; J J van Lanschot; C P Stoutenbeek; S J van Deventer; C L Wells; D J Gouma
Journal:  Br J Surg       Date:  1997-10       Impact factor: 6.939

9.  Increased levels of human hepatocyte growth factor in serum and peritoneal fluid after partial hepatectomy.

Authors:  F Kimura; M Miyazaki; T Suwa; S Kakizaki; H Itoh; T Kaiho; S Ambiru; H Shimizu; A Togawa
Journal:  Am J Gastroenterol       Date:  1996-01       Impact factor: 10.864

10.  Interleukin-6 as a marker of hepatic metabolism following hepatectomy.

Authors:  H Maruyama; A Harada; T Kurokawa; T Nonami; A Nakao; H Takagi
Journal:  Hepatogastroenterology       Date:  1994-06
View more
  5 in total

1.  Assessment of pharmacokinetic interaction between rilotumumab and epirubicin, cisplatin and capecitabine (ECX) in a Phase 3 study in gastric cancer.

Authors:  Yilong Zhang; Mita Kuchimanchi; Min Zhu; Sameer Doshi; Tien Hoang; Sreeneeranj Kasichayanula
Journal:  Br J Clin Pharmacol       Date:  2016-12-13       Impact factor: 4.335

2.  Major hepatectomy induces phenotypic changes in circulating dendritic cells and monocytes.

Authors:  Philip A Efron; Tadashi Matsumoto; Priscilla F McAuliffe; Philip Scumpia; Ricardo Ungaro; Shiro Fujita; Lyle L Moldawer; David Foley; Alan W Hemming
Journal:  J Clin Immunol       Date:  2009-04-22       Impact factor: 8.317

3.  VIP inhibits human HepG2 cell proliferation in vitro.

Authors:  Afaf Absood; Bin Hu; Nermine Bassily; Lisa Colletti
Journal:  Regul Pept       Date:  2007-11-21

4.  Hypoxia-induced inflammation and purinergic signaling in cross clamping the human aorta.

Authors:  Juho Jalkanen; Mikael Maksimow; Sirpa Jalkanen; Harri Hakovirta
Journal:  Springerplus       Date:  2016-01-04

5.  Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration.

Authors:  Barbara Lukomska; Joanna Dluzniewska; Jerzy Polanski; Leszek Zajac
Journal:  Comp Hepatol       Date:  2004-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.